Furthermore, the expression of CARF (collaborator of p14ARF)/CDKN2AIP mRNA that has been shown to regulate Wnt/β-catenin mediated EMT in cancer cells [18] showed a significant decrease in Wi-ACAPE-treated cells. This evidence concerns the gene CDKN2A and cancer.